114 related articles for article (PubMed ID: 2824776)
1. Chiral DNA gyrase inhibitors. 2. Asymmetric synthesis and biological activity of the enantiomers of 9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H- pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid (ofloxacin).
Mitscher LA; Sharma PN; Chu DT; Shen LL; Pernet AG
J Med Chem; 1987 Dec; 30(12):2283-6. PubMed ID: 2824776
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antibacterial activities of optically active ofloxacin.
Hayakawa I; Atarashi S; Yokohama S; Imamura M; Sakano K; Furukawa M
Antimicrob Agents Chemother; 1986 Jan; 29(1):163-4. PubMed ID: 3460520
[TBL] [Abstract][Full Text] [Related]
3. Chiral DNA gyrase inhibitors. 1. Synthesis and antimicrobial activity of the enantiomers of 6-fluoro-7-(1-piperazinyl)-1-(2'-trans-phenyl-1'-cyclopropyl)-1, 4-dihydro-4-oxoquinoline-3-carboxylic acid.
Mitscher LA; Sharma PN; Chu DT; Shen LL; Pernet AG
J Med Chem; 1986 Oct; 29(10):2044-7. PubMed ID: 3020253
[TBL] [Abstract][Full Text] [Related]
4. Isolation and identification of metabolites of ofloxacin in rats, dogs and monkeys.
Sudo K; Okazaki O; Tsumura M; Tachizawa H
Xenobiotica; 1986 Aug; 16(8):725-32. PubMed ID: 3464137
[TBL] [Abstract][Full Text] [Related]
5. Antimycoplasmal activities of (S)-(-)-9-fluoro-2,3-dihydro-3-methyl-10 -[4-(2-pyridyl)-1-piperazinyl]-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine -6-carboxylic acid (YH-6) in comparison with other antibiotics in vitro.
Ye H; Wu JM; Yang YS; Ji RY; Chen KX
Zhongguo Yao Li Xue Bao; 1999 Nov; 20(11):1031-4. PubMed ID: 11270970
[TBL] [Abstract][Full Text] [Related]
6. Antimycoplasmal activity of ofloxacin (DL-8280).
Osada Y; Ogawa H
Antimicrob Agents Chemother; 1983 Mar; 23(3):509-11. PubMed ID: 6573869
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of wild-type and resistant Escherichia coli and its DNA gyrase by the tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomers.
Wolfson JS; Hooper DC; Ng EY; Souza KS; McHugh GL; Swartz MN
Antimicrob Agents Chemother; 1987 Nov; 31(11):1861-3. PubMed ID: 2829717
[TBL] [Abstract][Full Text] [Related]
8. Effects of ethylenediaminetetraacetic acid and gentamicin on the antibacterial activity of pyridone carboxylic acid derivatives against gram-negative bacilli.
Miyake Y; Mitsui K; Suginaka H
J Antimicrob Chemother; 1986 Mar; 17(3):327-32. PubMed ID: 3084441
[TBL] [Abstract][Full Text] [Related]
9. International experiences with ofloxacin, a new quinolone.
Mitsuhashi S
Infection; 1986; 14 Suppl 4():S223-5. PubMed ID: 3028965
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibacterial activities of substituted 7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxyl ic acids.
Hayakawa I; Hiramitsu T; Tanaka Y
Chem Pharm Bull (Tokyo); 1984 Dec; 32(12):4907-13. PubMed ID: 6534539
[No Abstract] [Full Text] [Related]
11. Chiral DNA gyrase inhibitors. 3. Probing the chiral preference of the active site of DNA gyrase. Synthesis of 10-fluoro-6-methyl-6,7-dihydro-9-piperazinyl- 2H-benzo[a]quinolizin-20-one-3-carboxylic acid analogues.
Fecik RA; Devasthale P; Pillai S; Keschavarz-Shokri A; Shen L; Mitscher LA
J Med Chem; 2005 Feb; 48(4):1229-36. PubMed ID: 15715489
[TBL] [Abstract][Full Text] [Related]
12. Pyridonecarboxylic acids as antibacterial agents. IX. Synthesis and structure-activity relationship of 3-substituted 10-(1-aminocyclopropyl)-9-fluoro-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]- 1,4-benzoxazine-6-carboxylic acids and their 1-thio and 1-aza analogues.
Todo Y; Takagi H; Iino F; Fukuoka Y; Takahata M; Okamoto S; Saikawa I; Narita H
Chem Pharm Bull (Tokyo); 1994 Dec; 42(12):2569-74. PubMed ID: 7697774
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of differential activities of ofloxacin enantiomers.
Morrissey I; Hoshino K; Sato K; Yoshida A; Hayakawa I; Bures MG; Shen LL
Antimicrob Agents Chemother; 1996 Aug; 40(8):1775-84. PubMed ID: 8843280
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of DNA gyrase by optically active ofloxacin.
Imamura M; Shibamura S; Hayakawa I; Osada Y
Antimicrob Agents Chemother; 1987 Feb; 31(2):325-7. PubMed ID: 3032098
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7 H- pyridol[1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161).
Coughlin SA; Danz DW; Robinson RG; Klingbeil KM; Wentland MP; Corbett TH; Waud WR; Zwelling LA; Altschuler E; Bales E
Biochem Pharmacol; 1995 Jun; 50(1):111-22. PubMed ID: 7605336
[TBL] [Abstract][Full Text] [Related]
16. [Biotransformation of selected gyrase inhibitors].
Borner K; Lode H
Infection; 1986; 14 Suppl 1():S54-9. PubMed ID: 3007367
[TBL] [Abstract][Full Text] [Related]
17. New "ofloxacin" type antibacterial agents. Incorporation of the spiro cyclopropyl group at N-1.
Kiely JS; Schroeder MC; Sesnie JC
J Med Chem; 1988 Oct; 31(10):2004-8. PubMed ID: 3172136
[TBL] [Abstract][Full Text] [Related]
18. 5-Alkoxyimidazoquinolones as potential antibacterial agents. Synthesis and structure-activity relationships.
Fujita M; Egawa H; Miyamoto T; Nakano J; Matsumoto J
Chem Pharm Bull (Tokyo); 1996 May; 44(5):987-90. PubMed ID: 8689728
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
